COMMUNIQUÉS West-GlobeNewswire

Better Choice Company Board of Directors Approves Up to 55% Annual Royalty Distribution Plan from its Halo Brand

17/03/2025 - 18:28

TAMPA, Fla., March 17, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that its Board of Directors have [...]

Bon Natural Life Limited Announces Pricing of $12 Million Best Efforts Offering

17/03/2025 - 14:00

XI’AN, China, March 17, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries [...]

Scientists Solve One of Genomics’ Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes

17/03/2025 - 14:05

MENLO PARK, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications [...]

Alpha Bites Gummies: The Science, Ingredients, and Real User Experiences Behind This Natural Male Vitality Formula

17/03/2025 - 14:08

Backed by research and real testimonials, Alpha Bites Gummies offer a natural approach to enhancing stamina, energy, and overall male wellness LAKELAND, Fla., March 17, 2025 (GLOBE NEWSWIRE) -- The wellness industry is [...]

Capricor Therapeutics Announces Positive Data Demonstrating Long-Term Efficacy of Deramiocel for the Treatment of Duchenne Muscular Dystrophy

17/03/2025 - 14:25

--Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease-- --Data Presented at the 2025 Muscular Dystrophy Association (MDA) Conference-- SAN DIEGO, March 17, 2025 (GLOBE [...]

Lytus Technologies announces 24% Revenue Growth for H1 FY2025

17/03/2025 - 14:40

Mumbai, India, March 17, 2025 (GLOBE NEWSWIRE) -- Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT), a leader in platform services and next-generation technology, today announced its consolidated financial results for [...]

Cellphire Therapeutics CLPH-511 Fast Track Designation Granted

17/03/2025 - 15:00

FDA has granted CLPH-511 Fast Track Designation for the treatment of acute hemorrhage as an alternative to conventional platelets when not available or in short supply ROCKVILLE, Md., March 17, 2025 (GLOBE NEWSWIRE) -- [...]

OrganOx and ProCure On-Demand Announce Partnership to Expand Access for Liver Transplants

17/03/2025 - 15:32

Collaboration enhances efficiency and quality in liver recovery and availability OXFORD, United Kingdom and NEW YORK, March 17, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., the pioneering company transforming organ [...]

Wellinks and CareAbout Health Partner to Expand Value-Based COPD Management in New Jersey and Florida

17/03/2025 - 16:00

Collaboration Enhances Access to Value-Based Care for COPD Patients NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Wellinks, a digital healthcare company specializing in Chronic Obstructive Pulmonary Disease (COPD [...]

New Research Reveals One Million More Glaucoma Cases Than Previously Believed — Glaucoma Research Foundation Urges Early Screening

17/03/2025 - 16:02

Catching glaucoma in its beginning stages can prevent blindness. SAN FRANCISCO, March 17, 2025 (GLOBE NEWSWIRE) -- The Glaucoma Research Foundation (GRF) is launching a national awareness campaign, “Your Eyes Say Thanks [...]

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

17/03/2025 - 16:15

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 17 MARCH 2025 at 17.15 EET Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion [...]

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01

17/03/2025 - 11:45

STAFFORD, Texas, March 17, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]

Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia

17/03/2025 - 12:00

Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström Macroglobulinemia First-in-class Bruton’s tyrosine kinase (BTK) degrader NX-5948 assigned nonproprietary [...]

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

17/03/2025 - 12:00

WATERTOWN, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious [...]

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

17/03/2025 - 12:00

– Gino Santini Appointed as Chairman of the Board, Michael Heffernan, Founder and Chairman and Gwen A. Melincoff, Board Member to Retire from Board – – Dr. Carlos Paya Nominated to Board of Directors – – New Executives [...]

Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System

17/03/2025 - 12:00

DeepView ® System outperforms burn physicians in identifying non-healing tissue Landmark Burn Validation Study, one of the largest in U.S. history, confirms DeepView’s performance Spectral AI plans FDA submission by mid [...]

Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific

17/03/2025 - 12:00

EPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test Accuracy MISSISSAUGA, Ontario and MELBOURNE, Australia, March 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. ( TSX: MBX, OTCQX: [...]

Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome

17/03/2025 - 12:00

Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out Tech Transfer and Analytical Method Activities, including [...]

Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS

17/03/2025 - 12:01

sNDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved, FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney condition and a [...]